Aim: To establish a clinical research network that can design and rapidly implement ICH-compliant, high quality, large-scale, multi-site clinical studies in preparation for and response to outbreaks in Sub Saharan Africa (SSA).

 

........................................................................................................................................... December 2019

FISSA study to open soon!

ALERRT's Fever in Subsaharan Africa (FISSA) study has now been registered on the ISRCTN clinical trials registry

The FISSA study is expected to open to recruitment on the 16th of December.

 

........................................................................................................................................... November 2019

Anani Badje and Robert Akpata from PAC-CI have been working hard to get all of the FISSA sites trained and ready to start. See below for photos of training sessions held at CHR d'Ayamé, Côte d'Ivoire; St. Francis Xavier Hospital, Ghana; CHU de Treichville, Côte d'Ivoire; Clinical Service Department of Fajara, Gambia; Children's Hospital of Diamniadio, Senegal and CHU de Fann, Senegal.

          

 

.................................................................................................................................................... May 2019

Site selection for Core Study

The site selection process for clinical sites participating in the ALERRT Core Study began in August 2018. A selection procedure was written and assessment forms were developed for clinical sites and partners. Out of a total of 27 sites proposed 16 were selected, including 8 in West Africa, 4 in Central Africa and 4 in East Africa. This list was endorsed by the ALERRT Executive Committee at a meeting held on March 19th in Dakar, Senegal. For a comprehensive list and map of the sites operating across ALERRT, see here.